Sex differences in opioid use and medical issues during buprenorphine/naloxone treatment

References

• Center for Behavioral Health Statistics and Quality. Key substance use and mental health indicators in the United States: results from the 2015 National Survey on Drug Use and Health (HHS Publication No. SMA 16-4984, NSDUH Series H-51). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, 2016.
   Google Scholar
• Jones HE, Fitzgerald H, Johnson RE. Males and females differ in response to opioid agonist medications. The American joAm J Addict. 2005;14(3):223–33. Epub 2005/ 07/16.
   PubMed Web of Science ®Google Scholar
• Back SE, Payne RL, Simpson AN, Brady KT. Gender and prescription opioids: findings from the national survey on drug use and health. Addict Behav. 2010;35(11):1001–07. Epub 2010/ 07/06. doi:10.1016/j.addbeh.2010.06.018.
   PubMed Web of Science ®Google Scholar
• CDC. Vital signs: prescription painkiller overdoses. A Growing Epidemic, Especially Among Women. July 2013 [accessed 2017 Aug 20] http://www.cdc.gov/vitalsigns/prescriptionpainkilleroverdoses/index.html.
   Google Scholar
• Kaiser Family Foundation. Opioid overdose deaths by gender. 2017 [accessed 2017 Aug 20] http://www.kff.org/other/state-indicator/opioid-overdose-deaths-by-gender/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D.
   Google Scholar
• Davids E, Gastpar M. Buprenorphine in the treatment of opioid dependence. European neuropsychopharmacology. J Eur Coll Neuropsychopharmacol. 2004;14(3):209–16. Epub 2004/ 04/02. doi:10.1016/S0924-977X(03)00146-9.
   PubMed Web of Science ®Google Scholar
• Johnson RE, Eissenberg T, Stitzer ML, Strain EC, Liebson IA, Bigelow GE. A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug Alcohol Depend. 1995;40(1):17–25. Epub 1995/ 11/01. doi:10.1016/0376-8716(95)01186-2.
   PubMed Web of Science ®Google Scholar
• McPherson S, Barbosa-Leiker C, McDonell M, Howell D, Roll J. Longitudinal missing data strategies for substance use clinical trials using generalized estimating equations: an example with a buprenorphine trial. Hum Psychopharmacol. 2013;28(5):506–15. Epub 2013/ 09/10. doi:10.1002/hup.2339.
   PubMed Web of Science ®Google Scholar
• McPherson S, Barbosa-Leiker C, Mamey MR, McDonell M, Enders CK, Roll J. A ‘missing not at random’ (MNAR) and ‘missing at random’ (MAR) growth model comparison with a buprenorphine/naloxone clinical trial. Addiction. 2015;110(1):51–58. Epub 2014/ 08/30. doi:10.1111/add.12714.
   PubMed Web of Science ®Google Scholar
• McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, O'Brien CP. New data from the addiction severity index. Reliability and validity in three centers. J Nerv Ment Dis. 1985;173(7):412–23. Epub 1985/ 07/01. doi:10.1097/00005053-198507000-00005.
   PubMed Web of Science ®Google Scholar
• Cacciola JS, Alterman AI, McLellan AT, Lin YT, Lynch KG. Initial evidence for the reliability and validity of a “Lite” version of the addiction severity index. Drug Alcohol Depend. 2007;87(2–3):297–302. Epub 2006/ 10/19. doi:10.1016/j.drugalcdep.2006.09.002.
   PubMed Web of Science ®Google Scholar
• Murphy SM, Dweik D, McPherson S, Roll JM. Association between hepatitis C virus and opioid use while in buprenorphine treatment: preliminary findings. Am J Drug Alcohol Abuse. 2015;41(1):88–92. Epub 2014/ 12/10. doi:10.3109/00952990.2014.983274.
   PubMed Web of Science ®Google Scholar
• Back SE, Payne RL, Wahlquist AH, Carter RE, Stroud Z, Haynes L, Hillhouse M, et al. Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial. Am J Drug Alcohol Abuse. 2011;37(5):313–23. Epub 2011/ 08/23. doi:10.3109/00952990.2011.596982.
   PubMed Web of Science ®Google Scholar
• Brown LS Jr., Alterman AI, Rutherford MJ, Cacciola JS, Zaballero AR. Addiction Severity Index scores of four racial/ethnic and gender groups of methadone maintenance patients. J Subst Abuse. 1993;5(3):269–79. Epub 1993/ 01/01. doi:10.1016/0899-3289(93)90068-M.
   PubMedGoogle Scholar
• McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9(3):199–213. Epub 1992/ 01/01. doi:10.1016/0740-5472(92)90062-S.
   PubMed Web of Science ®Google Scholar
• Ling W, Hillhouse M, Domier C, Doraimani G, Hunter J, Thomas C, Jenkins J, et al. Buprenorphine tapering schedule and illicit opioid use. Addiction. 2009;104(2):256–65. Epub 2009/ 01/20. doi:10.1111/j.1360-0443.2008.02455.x.
   PubMed Web of Science ®Google Scholar
• Meredith W, Tisak J. Latent curve analysis. Psychometrika. 1990;55(1):107–22. doi:10.1007/BF02294746.
   Web of Science ®Google Scholar
• McPherson S, Barbosa-Leiker C, Burns GL, Howell D, Roll J. Missing data in substance abuse treatment research: current methods and modern approaches. Exp Clin Psychopharmacol. 2012;20(3):243–50. doi:10.1037/a0027146.
   PubMed Web of Science ®Google Scholar
• Muthén LK, Muthén BO. Mplus User’s Guide. Sixth. Los Angeles, CA: Muthén & Muthén. 1998–2015.
   Google Scholar
• Hernandez-Avila CA, Rounsaville BJ, Kranzler HR. Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend. 2004;74(3):265–72. Epub 2004/ 06/15. doi:10.1016/j.drugalcdep.2004.02.001.
   PubMed Web of Science ®Google Scholar
• NIDA. NIDA notes: gender differences in drug abuse risks and treatment. September, 2000 [accessed 2017 Aug 20] http://archives.drugabuse.gov/NIDA_Notes/NNVol15N4/Tearoff.html.
   Google Scholar
• McCaul ME, Svikis DS, Moore RD. Predictors of outpatient treatment retention: patient versus substance use characteristics. Drug Alcohol Depend. 2001;62(1):9–17. Epub 2001/ 02/15. doi:10.1016/S0376-8716(00)00155-1.
   PubMed Web of Science ®Google Scholar
• Kreek MJ, Borg L, Ducat E, Ray B. Pharmacotherapy in the treatment of addiction: methadone. J Addict Dis. 2010;29(2):200–16. Epub 2010/ 04/22. doi:10.1080/10550881003684798.
   PubMed Web of Science ®Google Scholar
• Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, Lincoln M, et al. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86(1):1–21. Epub 2006/ 06/09. doi:10.1016/j.drugalcdep.2006.05.012.
   PubMed Web of Science ®Google Scholar